Hepatitis C virus evasion mechanisms from neutralizing antibodies
about
Toward a Hepatitis C Virus Vaccine: the Structural Basis of Hepatitis C Virus Neutralization by AP33, a Broadly Neutralizing AntibodyAcute emergence and reversion of influenza A virus quasispecies within CD8+ T cell antigenic peptidesCapitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine designDifferent requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmissionHepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy.The Humoral Immune Response to HCV: Understanding is Key to Vaccine Development.Deep sequencing of hepatitis C virus hypervariable region 1 reveals no correlation between genetic heterogeneity and antiviral treatment outcomeNew insight into HCV E1/E2 region of genotype 4a.Hepatitis C virus infection: establishment of chronicity and liver disease progressionApproaching rational epitope vaccine design for hepatitis C virus with meta-server and multivalent scaffoldingApolipoprotein E, but Not Apolipoprotein B, Is Essential for Efficient Cell-to-Cell Transmission of Hepatitis C VirusNeutralizing antibodies and pathogenesis of hepatitis C virus infection.Neutralization interfering antibodies: a "novel" example of humoral immune dysfunction facilitating viral escape?Ultradeep pyrosequencing of hepatitis C virus hypervariable region 1 in quasispecies analysis.Immunologic, metabolic and genetic factors in hepatitis C virus infection.Clinical impact of hepatitis B and C virus envelope glycoproteins.Virus-neutralizing antibodies to hepatitis C virus.Current progress in development of hepatitis C virus vaccines.Multiantibody strategies for HIV.Multiple infections and cancer: implications in epidemiology.Trans-splicing group I intron targeting hepatitis C virus IRES mediates cell death upon viral infection in Huh7.5 cells.Monoclonal anti-envelope antibody AP33 protects humanized mice against a patient-derived hepatitis C virus challenge.Host-targeting therapies for hepatitis C virus infection: current developments and future applications.Hepatitis C Virus (HCV)-Apolipoprotein Interactions and Immune Evasion and Their Impact on HCV Vaccine Design.Immune Evasion by Viruses
P2860
Q27673453-E73334B1-9CE8-4AFB-8DA9-636D3464D4C7Q27687391-7363196F-CDA7-4355-9131-F808EE83E86EQ30374314-6C5BC766-2F98-449D-B37C-4064DE44BB01Q30541733-D5618CAD-B05B-4812-A8DC-687E7533AF97Q34008754-15385E1E-A5A6-4AB3-9794-51D190687424Q34481429-D516BE9F-92A6-43B7-BBA6-963BB85E7103Q34485144-ECB22F3E-1AB0-4168-B5AC-6E9ACC3C39DEQ35005196-FF6C9E11-0FBA-4E30-8B1A-F5BCCBB40F47Q35728873-C3E48F48-320F-4CC7-B519-A2625E09675CQ35942829-95995E05-3388-4768-A47B-0BD877D9CB11Q36080826-8ED418E8-6023-4662-86EC-75336F3235DCQ36395837-7C419F9A-D33E-49F4-AE22-B5537E17B849Q36404194-A9C10E1E-2ED0-4063-BC7D-0F5CBA2C5E34Q36848233-84C41E25-545F-4F06-8A62-72EE8174ED3CQ37682496-293D7726-4904-433B-9F2F-BBC29ED698A5Q38083515-77E4954B-BCC6-4C54-A49B-AAF4503FAAE9Q38104471-2CC022A5-0993-4CCA-9A6C-47E02A643E77Q38120201-8224965B-7DF0-4B14-9D9C-36BC4B4F0624Q38120526-6B8F502F-8D3A-4BDF-A25B-27A0B1C55858Q38126931-F0F65836-826B-45E9-836D-DC20719DB686Q38891212-093374D1-64E6-419A-9DF8-336D8AB69C91Q40165519-C94C8171-3539-4EC2-A357-12937B3879A1Q55280981-C6B44AED-2C5B-416C-B5DF-B2D048083742Q55513556-FED910F7-1358-438E-87CB-FA0798A984C5Q56922021-B90F7F67-FD9B-45DC-B0B0-B6EC70A9AACC
P2860
Hepatitis C virus evasion mechanisms from neutralizing antibodies
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Hepatitis C virus evasion mechanisms from neutralizing antibodies
@en
Hepatitis C virus evasion mechanisms from neutralizing antibodies.
@nl
type
label
Hepatitis C virus evasion mechanisms from neutralizing antibodies
@en
Hepatitis C virus evasion mechanisms from neutralizing antibodies.
@nl
prefLabel
Hepatitis C virus evasion mechanisms from neutralizing antibodies
@en
Hepatitis C virus evasion mechanisms from neutralizing antibodies.
@nl
P2093
P2860
P921
P356
P1433
P1476
Hepatitis C virus evasion mechanisms from neutralizing antibodies
@en
P2093
Allan G N Angus
Arvind H Patel
Caterina Di Lorenzo
P2860
P304
P356
10.3390/V3112280
P5008
P577
2011-11-01T00:00:00Z
2011-11-15T00:00:00Z